EUVIMEDEUVIMED entdecken
Scoping ReviewOpen Access · CC BY 4.0

Use of healthcare administrative claims data in observational studies of antirheumatic drug effects on pregnancy outcomes: A scoping review

Shenthuraan Tharmarajah iD, Araniy Santhireswaran, Yasmeen Ameeriar iD, Lisa M McCarthy, Dharini Mahendira, Howard Berger, Mina Tadrous, Sara J T Guilcher

PLOS ONE · 2025

DOI: 10.1371/journal.pone.0319703 ↗

Kurz gefasst

Scoping Review in der Zeitschrift PLOS ONE, 2025. Verfasst von Shenthuraan Tharmarajah und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Sciences, Leslie Dan Faculty of Pharmacy, University of Toronto, Toronto, Ontario, Canada. Hauptthemen laut MEDLINE: Pregnancy Outcome, Antirheumatic Agents, Pregnancy Complications, Administrative Claims, Healthcare. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The safety of antirheumatic drugs in pregnancy and their impact on maternal and neonatal outcomes are understudied. Despite pregnant individuals being excluded from clinical trials, their continued use of medications raises the importance of addressing knowledge gaps regarding safety and impact on outcomes. A scoping review was conducted following JBI methodology and PRISMA reporting guidelines to describe how antirheumatic drugs and associated adverse pregnancy outcomes have been investigated in observational studies using claims data. Electronic databases (MEDLINE (Ovid), Embase (Ovid), and CINAHL (EBSCO)) and grey literature were searched for observational studies using claims data to evaluate antirheumatic drug effects on pregnancy outcomes in individuals with rheumatic diseases. Of 4,325 articles identified, 38 eligible articles were included. The effects of conventional synthetic disease-modifying antirheumatic drugs (n = 37, 97.4%) and tumor necrosis factor inhibitor biological agents (n = 23, 60.5%) were extensively reported. Preterm birth (n = 25, 65.8%), preeclampsia (n = 17, 44.7%), stillbirth (n = 17, 44.7%), caesarean delivery (n = 16, 42.1%), and congenital anomalies (n = 14, 36.8%) were the most reported adverse pregnancy outcomes. Of 14 studies reporting congenital anomalies, 12 (85.7%) specified ICD codes and 4 (28.6%) specified validated definitions for identification in claims data, the most of any reported adverse pregnancy outcome. We found considerable ambiguity and heterogeneity in adverse pregnancy outcome definitions in claims data. There is a need for greater transparency and consistency in outcome reporting in observational studies using claims data. Protocol registration details: OSF, https://osf.io/5e6tp

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pregnancy OutcomeAntirheumatic AgentsPregnancy ComplicationsAdministrative Claims, HealthcareHumansPregnancyFemaleObservational Studies as TopicRheumatic DiseasesPremature Birth

Substanzen

Antirheumatic Agents

Autor:innen und Institutionen

  • Department of Pharmaceutical Sciences, Leslie Dan Faculty of Pharmacy, University of Toronto, Toronto, Ontario, Canada.
  • Institute for Better Health, Trillium Health Partners, Mississauga, Ontario, Canada.
  • Women's College Research Institute, Women's College Hospital, Toronto, Ontario, Canada.
  • Division of Rheumatology, St. Michael's Hospital, Toronto, Ontario, Canada.
  • Department of Medicine, University of Toronto, Toronto, Ontario, Canada.
  • Division of Maternal Fetal Medicine and Obstetric Ultrasound, St. Michael's Hospital, Toronto, Ontario, Canada.

ORCID-Profile: Shenthuraan Tharmarajah, Yasmeen Ameeriar

Zitieren

APA

Tharmarajah, S., Santhireswaran, A., Ameeriar, Y., McCarthy, L. M., Mahendira, D., Berger, H., Tadrous, M., & Guilcher, S. J. T. (2025). Use of healthcare administrative claims data in observational studies of antirheumatic drug effects on pregnancy outcomes: A scoping review. PLOS ONE. https://doi.org/10.1371/journal.pone.0319703

Vancouver

Tharmarajah S, Santhireswaran A, Ameeriar Y, McCarthy LM, Mahendira D, Berger H, et al. Use of healthcare administrative claims data in observational studies of antirheumatic drug effects on pregnancy outcomes: A scoping review. PLOS ONE. 2025. doi:10.1371/journal.pone.0319703

BibTeX
@article{Tharmarajah2025,
  author = {Tharmarajah, Shenthuraan and Santhireswaran, Araniy and Ameeriar, Yasmeen and McCarthy, Lisa M and Mahendira, Dharini and Berger, Howard and Tadrous, Mina and Guilcher, Sara J T},
  title = {Use of healthcare administrative claims data in observational studies of antirheumatic drug effects on pregnancy outcomes: A scoping review},
  journal = {PLOS ONE},
  year = {2025},
  doi = {10.1371/journal.pone.0319703}
}
Kostenlos starten →